Learn
This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints new CEO; MAPS and Wesana...
“HPPD is precisely the kind of risk that could fall through the cracks," says journalist Ed Prideaux, who suffers from...
Chief Medical Officer Guy Goodwin calls study "a strong signal that COMP360 psilocybin therapy could be an adjunctive treatment to...
This week in psychedelic business news: Wesana Health files a new patent, Silo Pharma is granted a patent, and 2...
Further in vivo studies with PSIL-002 will evaluate its antidepressant, anxiolytic, and anti-addictive properties, specifically targeting alcohol consumption....
Evidence supports the idea that the possibly unpleasant nature of the psychedelic experience is an integral part of its therapeutic...
The report also explores how microdosing may impact the use of other prescribed mental health medications....
From a fantastic companion book to critically acclaimed documentary "Fantastic Fungi" to a new vinyl called "Music for Psychedelic Therapy,"...
This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a Cybin study for Covid-19 distress;...
Two industry insiders weigh in on the question as more and more of the world's biggest stars publicly share psychedelic...